Skip to content

Exploring the Therapeutic Efficacy of Combining Olfactory Pleasure Activation with Cognitive Training for Improving Mild Cognitive Impairment

Exploring the Therapeutic Efficacy of Combining Olfactory Pleasure Activation with Cognitive Training for Improving Mild Cognitive Impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100482
Enrollment
Unknown
Registered
2025-04-10
Start date
2025-04-15
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Interventions

Control Group:Computerized cognitive training combined with micro-odor stimuli
Intervention Group:Computerized cognitive training combined with pleasant odor stimulation

Sponsors

Peking University Sixth Hospital ( Institute of Mental Health )
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Voluntary participation;Ability to understand and sign an informed consent form;Right-handed; 2.55 years of age or older, regardless of sex; 3.Elementary school education or higher (>=5 years of education); 4.The Petersen MCI diagnostic criteria were met: (1). Memory loss confirmed by the informant; (2). Evidence of objective cognitive impairment (MoCA 17 points for those with elementary school education, and >=24 points for those with junior high school education or above); (4). Ability to lead daily life basically normal (ADL <=26 points); and e. Did not meet the diagnostic criteria for dementia (according to ICD-10 and NINCDS-ADRDA) and have an overall Global CDR score of 0.5; 5.Hamilton Depression (HAMD) score <=7;

Exclusion criteria

Exclusion criteria: 1.Current use of anti-dementia medication (e.g. donepezil hydrochloride, memantine tablets, carboplatin, lencanelizumab, etc.); 2.Those with other conditions that affect olfactory function such as chronic rhinitis, allergic rhinitis, nasal polyps, and a history of upper respiratory tract infection in the last two weeks.

Design outcomes

Primary

MeasureTime frame
Total Delayed Paired Recall Change Values for Memory Binding Tests;

Secondary

MeasureTime frame
Changes in overall cognitive function;Changes in olfactory function;Neuroimaging changes;Changes in mood;

Countries

China

Contacts

Public ContactYu xin

Peking University Sixth Hospital ( Institute of Mental Health )

yuxin@bjmu.edu.cn+86 10 82801999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026